Galapagos NV
GLPG
#5076
Rank
C$2.61 B
Marketcap
C$38.99
Share price
0.00%
Change (1 day)
-12.55%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2026 (TTM): C-$0.76

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is C-$0.57. In 2025 the company made an earnings per share (EPS) of C$8.04 an increase over its 2024 EPS that were of C$1.64.

EPS history for Galapagos NV from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$0.76-109.45%
2025C$8.04390.86%
2024C$1.64-67.16%
2023C$4.99-199.64%
2022C-$5.0199.03%
2021C-$2.52-68.98%
2020C-$8.11-298.06%
2019C$4.10-554.64%
2018C-$0.90-77.18%
2017C-$3.95-326.21%
2016C$1.75-134.19%
2015C-$5.10-371.34%
2014C$1.88-445.98%
2013C-$0.5432.88%
2012C-$0.41-82.07%
2011C-$2.28-817.9%
2010C$0.3212.73%
2009C$0.28-120.79%
2008C-$1.36-37.67%
2007C-$2.1839.64%
2006C-$1.5628.17%
2005C-$1.226.25%
2004C-$1.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.28-2,244.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$5.07-985.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$2.89-604.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$3.60-728.35%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$5.03-977.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$9.77-1,806.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$5.46-1,054.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
C$5.05-981.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$1.93-436.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel